Quick Answer
PMV Pharmaceuticals, Inc. reported Shares Outstanding of 53.33 million shares for fiscal year 2025.
PMV Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 53.33M | +2.7% |
| 2024 | 51.94M | +1.0% |
| 2023 | 51.45M | +12.4% |
| 2022 | 45.77M | +0.7% |
| 2021 | 45.43M | +1.5% |
| 2020 | 44.78M | +1370.0% |
| 2019 | 3.05M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 52.99M | +2.4% | +0.0% |
| June 30, 2025 | 52.99M | +2.9% | +2.0% |
| March 31, 2025 | 51.95M | +1.0% | +0.0% |
| December 31, 2024 | 51.94M | +1.0% | +0.4% |
| September 30, 2024 | 51.75M | +1.2% | +0.4% |
| June 30, 2024 | 51.52M | +11.7% | +0.1% |
| March 31, 2024 | 51.45M | +12.4% | +0.0% |
| December 31, 2023 | 51.45M | +12.4% | +0.6% |
- PMV Pharmaceuticals, Inc. showed an increase of +2.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, PMV Pharmaceuticals, Inc.’s shares outstanding has grown by 1650.8% (from 3.05 million shares to 53.33 million shares).
- The most recent figure is from PMV Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: